Ranibizumab appears to reverse diabetes-related vision loss in some populations
by Bruce Sylvester: Ranibizumab (Lucentis®) therapy appears to have efficacy in reversing diabetes-related vision loss in some populations, researchers reported online on Feb. 19 in the journal Opthalmology.